Tolerability and Pharmacokinetic Analyses of Combination Therapy with Darolutamide (DARO), Androgen-Deprivation Therapy (ADT), and Docetaxel (DOC) in Patients with Metastatic Hormone Sensitive Prostate Cancer (mhspc) from ARASENS
JOURNAL OF CLINICAL ONCOLOGY(2023)
Key words
Metastatic Prostate Cancer,Cancer Treatment,Hormone Therapy
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined